Skip to Main Content

Paper Details

AMEERA-1 phase 1/2 study of amcenestrant, SAR439859, in postmenopausal women with ER-positive/HER2-negative advanced breast cancer.
Nat Commun
19
2022
Author NameAffiliation
Aditya BardiaMassachusetts General Hospital Cancer Center, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2